
Pharmacielo Ltd
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- $0.124
- Today's High:
- $0.16
- Open Price:
- $0.124
- 52W Low:
- $0.079
- 52W High:
- $0.344
- Prev. Close:
- $0.138
- Volume:
- 26400
Company Statistics
- Market Cap.:
- $20.85 million
- Book Value:
- 0.023
- Revenue TTM:
- $2.93 million
- Operating Margin TTM:
- -382.05%
- Gross Profit TTM:
- $-4171733
- Profit Margin:
- 0%
- Return on Assets TTM:
- -25.05%
- Return on Equity TTM:
- -172.1%
Company Profile
Pharmacielo Ltd had its IPO on under the ticker symbol PCLOF.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Pharmacielo Ltd has a staff strength of 0 employees.
Stock update
Shares of Pharmacielo Ltd opened at $0.12 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.12 - $0.16, and closed at $0.16.
This is a +15.94% increase from the previous day's closing price.
A total volume of 26,400 shares were traded at the close of the day’s session.
In the last one week, shares of Pharmacielo Ltd have increased by +19.4%.
Pharmacielo Ltd's Key Ratios
Pharmacielo Ltd has a market cap of $20.85 million, indicating a price to book ratio of 4.28 and a price to sales ratio of 7.2514.
In the last 12-months Pharmacielo Ltd’s revenue was $2.93 million with a gross profit of $-4171733 and an EBITDA of $-11105860. The EBITDA ratio measures Pharmacielo Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Pharmacielo Ltd’s operating margin was -382.05% while its return on assets stood at -25.05% with a return of equity of -172.1%.
In Q2, Pharmacielo Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 92.5%.
Pharmacielo Ltd’s PE and PEG Ratio
- Forward PE
- 5.8309
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.08 per share while it has a forward price to earnings multiple of 5.8309 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Pharmacielo Ltd’s profitability.
Pharmacielo Ltd stock is trading at a EV to sales ratio of 9.3563 and a EV to EBITDA ratio of -2.9605. Its price to sales ratio in the trailing 12-months stood at 7.2514.
Pharmacielo Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $25.83 million
- Total Liabilities
- $7.68 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Pharmacielo Ltd ended 2025 with $25.83 million in total assets and $0 in total liabilities. Its intangible assets were valued at $25.83 million while shareholder equity stood at $3.56 million.
Pharmacielo Ltd ended 2025 with $0 in deferred long-term liabilities, $7.68 million in other current liabilities, in common stock, $-189558353.00 in retained earnings and $0 in goodwill. Its cash balance stood at $105459.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $14.59 million.
Pharmacielo Ltd’s total current assets stands at $3.50 million while long-term investments were $369211.00 and short-term investments were $0.00. Its net receivables were $28603.00 compared to accounts payable of $0 and inventory worth $2.25 million.
In 2025, Pharmacielo Ltd's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Pharmacielo Ltd paid $0 in dividends in 2025.
Other key metrics
- Current Trading Price
- $0.16
- 52-Week High
- $0.344
- 52-Week Low
- $0.079
- Analyst Target Price
- $
Pharmacielo Ltd stock is currently trading at $0.16 per share. It touched a 52-week high of $0.344 and a 52-week low of $0.344. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.12 and 200-day moving average was $0.16 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 397.4% of the company’s stock are held by insiders while 557% are held by institutions.
Frequently Asked Questions About Pharmacielo Ltd
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. PharmaCielo Ltd. is headquartered in Toronto, Canada.